Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132286) titled 'Diagnostic efficacy of 64Cu-TRD2204 PET/CT in patients with urothelial carcinoma and breast cancer' on Sept. 11.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: First Medical Center, PLA General Hospital
Condition:
Urothelial carcinoma and breast cancer
Intervention:
Gold Standard:Comprehensive judgment based on histopathological/cytological examination (diagnostic gold standard) combined with conventional imaging (CT/MRI) and/or 18F-FDG PET/CT (lesion assessment criteria).
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-06
Target ...